The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
0.235
-0.029 (-10.84%)
At close: Nov 14, 2024, 4:00 PM
0.230
-0.005 (-2.21%)
Pre-market: Nov 15, 2024, 4:19 AM EST
The Oncology Institute Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -70.24 | -83.07 | 0.15 | -10.93 | -14.32 | -4.02 | Upgrade
|
| Depreciation & Amortization | 6.16 | 5.87 | 4.41 | 3.34 | 3.18 | 2.94 | Upgrade
|
| Other Amortization | 6.28 | 6.21 | 2.44 | 0.05 | 0.06 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | -0.03 | 0.02 | - | 0.06 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 16.87 | 9.94 | - | 7.5 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.77 | -2.88 | -0.64 | - | - | - | Upgrade
|
| Stock-Based Compensation | 13.94 | 17.81 | 27.68 | 24.54 | 0.15 | 0.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.99 | 2.02 | 0.48 | -0.42 | 4.23 | 0.33 | Upgrade
|
| Other Operating Activities | -1.78 | -1.47 | -85.7 | -34.78 | -1.34 | 0.82 | Upgrade
|
| Change in Accounts Receivable | -8.05 | -4.56 | -20.29 | -2.2 | -6.76 | -4.33 | Upgrade
|
| Change in Inventory | 2.1 | -4.39 | -1.73 | -1.84 | -0.47 | -1.13 | Upgrade
|
| Change in Accounts Payable | 9.57 | 5.06 | -6.19 | 2.92 | 3.76 | 5.53 | Upgrade
|
| Change in Income Taxes | -0.26 | -0.26 | 0.12 | -1.01 | 0.66 | 0.39 | Upgrade
|
| Change in Other Net Operating Assets | 8.4 | 6.51 | 7.54 | -12.36 | 3.81 | 2.99 | Upgrade
|
| Operating Cash Flow | -34.62 | -36.32 | -61.76 | -32.68 | 0.51 | 3.62 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -85.95% | -35.92% | Upgrade
|
| Capital Expenditures | -2.9 | -4.57 | -5.53 | -2.85 | -1.19 | -1.2 | Upgrade
|
| Cash Acquisitions | -0.16 | -4.46 | -8.58 | -9.11 | -0.15 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.2 | - | - | Upgrade
|
| Investment in Securities | 62.64 | 71.66 | -117.51 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | -7.5 | - | Upgrade
|
| Investing Cash Flow | 59.59 | 62.64 | -131.61 | -12.15 | -8.84 | -1.2 | Upgrade
|
| Long-Term Debt Issued | - | - | 110 | 8.43 | 12.49 | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.37 | -5.07 | -7.66 | -0.31 | -0 | Upgrade
|
| Net Debt Issued (Repaid) | -3.31 | -3.37 | 104.93 | 0.77 | 12.18 | -0 | Upgrade
|
| Issuance of Common Stock | 0.19 | 0.13 | 0.86 | - | 0.05 | - | Upgrade
|
| Repurchase of Common Stock | - | -1.02 | -9.41 | - | - | - | Upgrade
|
| Other Financing Activities | -1.99 | -2.58 | -4.17 | 133.24 | -0.34 | - | Upgrade
|
| Financing Cash Flow | -5.11 | -6.85 | 92.21 | 154.01 | 11.89 | -0 | Upgrade
|
| Net Cash Flow | 19.87 | 19.48 | -101.16 | 109.18 | 3.55 | 2.41 | Upgrade
|
| Free Cash Flow | -37.51 | -40.88 | -67.29 | -35.53 | -0.69 | 2.41 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -51.26% | Upgrade
|
| Free Cash Flow Margin | -9.90% | -12.61% | -26.65% | -17.50% | -0.37% | 1.55% | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -0.55 | -0.83 | -0.54 | -0.01 | - | Upgrade
|
| Cash Interest Paid | 4.51 | 4.51 | 0.22 | 0.28 | 0.23 | 0 | Upgrade
|
| Cash Income Tax Paid | 0.4 | 0.4 | 0.15 | 1.73 | 0.21 | 0.06 | Upgrade
|
| Levered Free Cash Flow | -7.5 | -16.33 | -40.79 | -13.34 | 2.37 | - | Upgrade
|
| Unlevered Free Cash Flow | -8.62 | -18.3 | -40.69 | -13.19 | 2.52 | - | Upgrade
|
| Change in Net Working Capital | -9.98 | -0.18 | 22.25 | 9.66 | -5.28 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.